The Evidence Based Rheumatology Podcast

Michael Putman
  • 5.0 (12)
  • MEDICINE
  • UPDATED SEMIMONTHLY

A weekly podcast for physicians interested in evidence based medicine and rheumatology. Find the papers at ebrheum.com

  1. SEP 22

    E127: TNFs and All That CHF

    Another episode looking into safety this week! Tackling that pesky issue of TNFs and CHF. Be sure to subscribe to my newsletter and check out the papers below!    Newsletter: https://sprw.io/stt-ee87b4 ATTACH: https://pubmed.ncbi.nlm.nih.gov/12796126/ RENEWAL: https://www.ahajournals.org/doi/10.1161/01.cir.0000124490.27666.b2 Observational Studies: https://pubmed.ncbi.nlm.nih.gov/23155221/

    22 min

  2. SEP 8

    E126: Risk Signals, JAKs, and SELECTIVE-ity

    Covering an interesting but ultimately disappointing post hoc study of multiple upadacitinib trials in RA. Initially some hope for clarity in the "Do JAKs cause all the badness?" questions, but ultimately landing me about where I have been since ORAL-SURVEILLANCE was published Paper: https://www.sciencedirect.com/science/article/pii/S0003496724423091

    15 min

  3. JUN 29

    E125: Adrenal Insufficiency after Stopping Prednisone

    Interesting read this week - I cover a nifty little paper that presented data about adrenal insufficiency after stopping prednisolone, published in JAMA Open in March 2025.     Open Access Journal Here: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2831668

    18 min

  4. JUN 12

    e124: MTX vs Pred for Pulmonary Sarcoidosis: PREDMETH Study

    Interesting NEJM trial this week comparing methotrexate to prednisone for pulmonary sarcoidosis. Paper available here: https://www.nejm.org/doi/full/10.1056/NEJMoa2501443

    14 min

  5. APR 30

    E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA

    Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial and an interesting topic. Paper itself here: https://www.nejm.org/doi/full/10.1056/NEJMoa2413449

    18 min

  6. APR 17

    E122: Guidelines for Maybe Diagnosing HLH

    This week I cover another of my newsletters, though I mostly use it as a skeleton to riff on a common (and challenging) issue for rheumatology consultants; diagnosing HLH. Check out the guidelines themselves here and have a listen to the podcast!    https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(23)00273-4/fulltext

    11 min

  7. APR 2

    E121: Obinutuzumab in SLE-LN

    Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, paper can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa2410965

    18 min

  8. MAR 6

    E120: Real Life Use of PEXIVAS-Low

    What do you do when observational data and RCTs conflict? This week I'm covering the "real world PEXIVAS" study that was done by the French Vasculitis Study Group. Great read, interesting issues, have a listen and be sure to share with friends!

    25 min
See All (100)

5
out of 5
12 Ratings

About

A weekly podcast for physicians interested in evidence based medicine and rheumatology. Find the papers at ebrheum.com

Information

You Might Also Like